A few examples of the products in J.A.K Marketing's 'ThinkGreen' portfolio include the Purfect Anaesorber, BAG’EMS biodegradable poop bags, Tick Twister products (made from recycled plastic) and Bamboo stick cotton buds.
The website also gives a snapshot of the sorts of things that J.A.K itself does to reduce its impact on the environment, including the use of environmentally-friendly brown paper and recycled cardboard boxes for packaging. The company has also switched to certified sustainable FSC paper for most of its printed marketing materials (including the master catalogue) and is working with courier companies who have targets in reducing CO2 emissions.
Managing Director, John Holland said: "J.A.K Marketing is committed to the protection and preservation of the world’s ecosystem. By undertaking our productivity and operations responsibly and sustainably, we recognise that reducing the environmental impact of our activities is very important. We will strive to achieve environmental excellence within the veterinary industry and will continue to work closely with our employees and commercial partners to establish and follow the principles of our ThinkGreen policy."
Sales Director, James Johnson said: "With growing interest towards the protection of the environment, we need to make it easier for veterinary practices to identify products where there is a benefit to the environment by simply switching to a like for like ‘greener’ alternative. As part of our long-term strategy, we are dedicated to growing this area of our business, welcoming feedback from the profession of how we can all work together to achieve this."
Those wanting to offer inspiration and feedback can do so on the form at the bottom of the ‘ThinkGreen’ page: www.jakmarketing.co.uk/thinkgreen.
The report also revealed the devastating impact on overworked veterinary staff, with some left in tears by abusive owners venting their frustration at being unable to find care for their animal.
Anecdotally, the problems highlighted by ITV News are being seen elsewhere in the country, with more and more vets now starting to question whether or not the current requirement to provide out of hours care is sustainable in a world where there are more clients who increasingly expect flea treatment advice and other non emergency situations to be dealt with at 3:00am in the morning.
Various solutions have been proposed in a forum discussion on VetSurgeon.org, including the removal of the requirement to provide an OOH service, for the RCVS to give vets the confidence to say no to non emergencies, a change to the CoPC to require vets to provide emergency care within 24 hours, not 24 hours a day, a requirement for new grads to undertake OOH as part of their PDP, and/or a requirement for OOH centres to have 3 vets on duty at any one time (which could improve working conditions).
As the ITV report pointed out, the fundamental issue is one of a shortage of supply over demand, for which there is no overnight fix. However, many feel that reducing the demands of providing OOH could ease the situation considerably.
Duoflect contains a new formulation of fipronil and (s)-methoprene which, according to the company, offers a 100% longer duration of action against fleas in cats (eight weeks), and a 13% longer duration in dogs (nine weeks) than the market-leading fipronil combination.
Ceva says the Duoflect's duration of action against ticks is 150% longer in cats (5 weeks) and 50% longer it cats (six weeks) than the market-leading competitor.
Duoflect acts against both adult fleas on the animal and immature flea stages in the environment and it can also be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).
Duoflect is available in free-standing pipettes for easier administration and handling of the pet. The pipettes are packed in child-resistant aluminium blisters to reduce the risk of accidents at home.
Nicki Glen, marketing project manager for Duoflect at Ceva Animal Health said: "Recent research1 has revealed that two main factors in prescribing parasitic control products are the length of action and the increased efficacy against fleas.
"Duoflect's new strength formulation provides a longer duration of action than the market-leading fipronil combination, while its efficacy is proven through 13 recent laboratory and field trials1."
Duoflect is competitively priced and is available in boxes of three or six pipettes and in five presentations: small cats (1-5kg), large cats (>5kg) and small dogs (2-10kg) and medium dogs (10-20kg), large dogs (20-40kg) and extra large dogs (40-60kg). It is suitable for cats and dogs from eight weeks of age.
Ceva Animal Health has produced a range of supporting marketing materials including client leaflets.
For more information, contact your local Ceva Animal Health territory manager or call Ceva’s head office on 01494 781510.
Reference
For the studies, the owners of 68 dogs treated with Librela and 44 cats treated with Solensia answered 22 questions in the case of dogs and 20 questions in the case of cats on VetMetrica, a digital HRQL instrument.
With a scale of 0-6, cats were rated on vitality, comfort and emotional wellbeing, and dogs on energetic/enthusiastic, happy/content, active/comfortable and calm/relaxed, over a period of 70 days.
The studies concluded that both Librela and Solensia produced a significant improvement in HRQL within 14 days of initial treatment, which was the first time the QOL impact was measured.
The improvement was maintained for the duration of the study.
Jacky Reid, BVMS PhD DVA, CEO of NewMetrica, now part of Zoetis, said: “Assessing and understanding how OA-related pain impacts emotional and physical well-being in particular circumstances, broadens the perspective in relation to pain management.
“HRQL measurements are not generally implemented in veterinary science at this time, so it’s exciting to see how it’s proving effective at adding value to existing functional measures.
"Particularly, helping us understand how pain management impacts the physical and emotional wellbeing of animals and will ultimately boost pet owner confidence.”
Oya Canbas, Zoetis UK General Manager, explained: “With an ever-growing bond between humans and animals, and pets leading longer lives, pet owners are more motivated than ever to support their pet’s wellbeing.
"However, not all are aware of the negative impacts of chronic disease, with signs of OA pain often mistaken as ‘normal’ signs of aging.
"This is why we need to increase awareness, to tackle under-diagnosis of OA pain.
"Common medications used to treat cases of OA pain that are diagnosed are often Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).
"While effective, these can have limitations, such as for middle aged to senior pets which have other diseases, requiring multiple medications.
"Some will not tolerate NSAIDs, and not all pets respond to NSAID therapy.
"So, expanding prescription choices is a privilege.”
References
Comments received from students included: "They are an extremely supportive team that are very keen to teach and get the students involved at every opportunity" and: "They are very good at getting students involved and making them feel like part of the team".
Other winners included Fiona Ridout, pictured right, who won the award for the most engaged veterinary student on EMS placement. She had consistently excellent feedback across all her placements and significantly exceeded the RCVS required number of weeks for pre-clinical and clinical EMS. Feedback comments included: "Fiona has been highly motivated and reliable, always keen to help and gain experience"; "Fiona is one of the best students that we've have ever had"; 'Her clinical knowledge improves each time she visits", and: "Interactions from staff and clients have been impressive".
Golden Valley Vets in Nailsea Park, Bristol won the students’ award for most supportive veterinary nursing placement practice. Comments received from students included: "All the staff were really friendly, welcoming and patient and I left feeling like part of the team", and: "I was actively encouraged and supported with my Nursing Progress Log during my time there".
Megan Piper won the award for the most engaged veterinary nursing student on EMS placement. Megan received excellent feedback from her EMS placements and from her rotations. Feedback comments included: "When Megan qualifies she will make an excellent nurse and a very valued member of any team"; "Megan has consistently demonstrated a professional, motivated approach to her work in practice", and: "Our Referral Vets and Clinical Director were all very sad that she has finished her placement with us, and have invited her to come back once she has qualified".
Veronica Roberts, Senior Clinical Fellow in Equine Medicine at the University of Bristol said: "The University of Bristol believes that EMS prizes encourage and acknowledge student learning in a practical ‘real world’ situation, thus supporting the university in its aim to prepare graduates for day one competencies and life-long learning. We are grateful to practices for the invaluable contribution they make towards student education through offering EMS placements."
Wendy Talbot, National Equine Veterinary Manager at Zoetis said: "At Zoetis we are dedicated to supporting animal health through a wide range of quality medicines, vaccines, services and education so we are proud to sponsor these important prizes. They enable winning students to choose a preferred academic resource to help support them during their important first years in practice, while the winning practices can be formally thanked for their invaluable commitment and support."
Alfaxan 10mg/mL solution for injection for dogs and cats is licensed as an induction agent prior to inhalation anaesthesia and as a sole anaesthetic agent for the induction and maintenance of anaesthesia for the performance of examination or surgical procedures. Jurox highlights that it has been safely used in patients from 12 weeks of age, for the induction of anaesthesia prior to delivery of puppies by caesarean section and for maintenance anaesthesia in procedures lasting up to an hour.
Jurox offers the following advice: "Part 1 (2) of Schedule 4 of the Veterinary Medicines Regulations states that 'if there is no authorised veterinary medicinal product' then the cascade may be followed. Alfaxan is an available and authorised veterinary medicinal product with very similar indications and therefore there is no clinical need to resort to non-licensed formulations of propofol, under cascade, for veterinary intravenous anaesthesia."
The company says that its UK team of veterinary surgeons will again respond proactively to the propofol shortage by delivering educational support to veterinary professionals and assisting them through the change to another veterinary licensed product for the anaesthesia of cats and dogs should they wish.
If you would like to discuss specific cases or need support using Alfaxan for the first time, contact Jurox on 0800 500 3171 or email alfaxan@jurox.co.uk
Bacteria isolated from human dental units analysed in other studies included Pseudomonas Sp, Mycobacteria and Legionella.
Bob said: "The Care Quality Commission (CQC) would have no hesitation in shutting down practices with the level of contamination we have seen. The dangers are real and significant for our teams as well as for our patients.
"Part of the problem is that dental units produce aerosols which can carry the bacteria into the depths of the lungs, bypassing normal defence mechanisms. Endotoxin levels have also been shown to be very high in untreated units, potentially resulting in problems when surgical extractions are performed.
Bob added: "The good news is that the biofilms which harbour the bacteria are treatable - but simply adding a little chlorhexidine will not do the trick."
Working with industry leaders, www.VetDentist.info has produced a Starter Kit for veterinary practices, which Bob says will clear biofilms and also provides a safe maintenance solution for ongoing use.
Bob says the cost of keeping your dental unit’s water lines safe for staff and patients is around 25-40p per day. Practices can also sign up for a regular monitoring scheme.
For more information and to get a VetDentist Starter Kit, visit www.VetDentist.info.
Norbrook is expanding its NSAID range with the launch of Loxicom Injection for cattle, pigs and horses.
Norbrook says the new product, which will be available to veterinary surgeons from mid-October, offers treatment for a range of symptoms including pneumonia, acute mastitis and calf scour in cattle, swine locomotor diseases such as lameness and MMA syndrome, acute and chronic musculo-skeletal disorders and equine colic.
Rebecca Pullon, Norbrook Product Manager said: "Loxicom is our tried and trusted NSAID range which has been available in suspension or injection for cats and dogs and which has proven exceptionally popular with veterinary practices. According to the GFK data, Norbrook is the most successful generic manufacturer of Meloxicam, by some distance.
"I am delighted that we can now extend this range to include a Loxicom Injection for Cattle, Pigs and Horses, which I am confident will prove equally as popular."
"As a bio-equivalent product, Loxicom Injection for cattle, pigs and horses is as effective as the pioneer product. There is a misperception that a bioequivalent product is somehow inferior to the pioneer product, which is untrue. In order to attain a license, a company must prove that a bio-equivalent product is at least as effective as the pioneer. With Loxicom Injection for cattle, pigs and horses, it comes with the added reassurance that it has been produced by Norbrook, a world leader in animal health and veterinary pharmaceuticals manufacture."
Stelfonta is licensed for the treatment of non-resectable, non-metastatic (WHO staging1) subcutaneous mast cell tumours (MCTs) located at or distal to the elbow or the hock, and non-resectable, non-metastatic cutaneous MCTs in dogs. Tumours must be less than or equal to 8cm3 in volume and must be accessible to intratumoural injection.
The company says that a single intratumoural treatment has been seen to destroy the tumour completely in 75% of observed cases.
The active ingredient in Stelfonta is tigilanol tiglate, a compound extracted from Fontainea picrosperma, a shrub found in the Australian rain forest. According to the company, it works largely through specific protein kinase c (PKC) activation, in which it locally stimulates the immune system, resulting in destruction of the tumour and the tumour’s blood supply, followed by rapid healing of the site with minimal scarring.
Virbac says that generally, dogs do not require sedation or local or general anaesthesia during treatment.
Dr Neil Mottram MRCVS, Technical Product Manager at Virbac said: "Stelfonta is an innovative yet simple treatment which provides a high tumour elimination rate, rapid healing and a speedy return to a good quality of life for the pet. In the cases studied, the tumour was destroyed in seven days and full wound healing observed in 96.5% of cases, with no significant adverse effects on the dog.
“The effects of Stelfonta really do need to be seen to be believed."
The group, which was convened by Boehringer Ingelheim, made its recommendation in a poster published at the National Mastitis Council meeting in Arizona1, prior to the launch of Boehringer's new teat sealant, Ubroseal.
The poster added that those animals that are likely to be infected need to receive antibiotic dry cow therapy (ADCT) in addition to a teat sealant.
Boehringer says various studies have shown that using an ITS reduces the risk of new intramammary infections and reduces the risk of clinical mastitis after calving, pointing to a meta-analysis of published papers which showed a 25% reduced risk of new infections and a 29% reduced risk of clinical mastitis for cows receiving ITS plus ADCT compared with ADCT alone
Boehringer’s veterinary adviser, Kath Aplin said: "Against the backdrop of targets from RUMA to reduce antibiotic use in the dairy sector3, adopting ITS for all cows could significantly reduce the need for antibiotics. An increase in the use of ITS is included in the dairy sector targets.
"We estimate that, currently, around 29% of the national herd is dried off without an ITS, so there is huge room for growth4."
Kath added: "With a 300-cow US study showing that a week after drying off, 47% of teats had still not formed a keratin plug5 and a New Zealand study showing that one in 20 cows had teats that remained open for 60 days6, it is clear to see that delayed teat closure is a very real problem in many herds. Teats remaining open after dry off make the udder highly susceptible to infection and delayed teat closure exacerbates the risk of acquiring an intramammary infection post-dry off4."
The expert group also recommended developing a herd plan, classifying herds as low risk or high risk and having a different approach to each.
High risk herds will have had a bulk SCC of >250,000 cell/ml in at least two of the last six months, they may also have a problem with Strep. agalactiae or could be experiencing an unavoidable risk period (a new building for example).
The priority should be to improve udder health management during both the lactation and dry period and any decision to abandon ADCT should be made with care and a full risk assessment.
The group said that in reality, it may be prudent to continue blanket ADCT until udder health has improved.
The group’s recommendations for low risk herds (<250,000 cells/ml in four out of the last six months) were to actively strive towards selective ADCT, supported by ITS for all cows.
The full recommendations are published in the proceedings of the NMC1 or can be obtained from your local Boehringer Ingelheim representative.
Kath said: "It has long been established that the mammary gland is highly susceptible to infection in the dry period and that the majority of clinical mastitis in early lactation is picked up during the dry period.
"Moving towards selective ADCT may not be appropriate immediately for all producers. However, the use of ITS for all cows on all farms will reduce new infection rates, assisting in the drive towards improved udder health and reduced antibiotic use."
Photo: Curious cattle on farmland in Cornwall UK. Shutterstock/Shzphoto
Veterinary students Harry Pink and Meg Coram have won the third Sutton Bonington Science Cake competition for their entry: Rhinos Should Be Horny (pictured right, click to enlarge).
The competition was held on the 12th March in aid of Comic Relief, with entries in six different categories (Veterinary Medicine, Animal & Agriculture, From Farm to Fork, Infection, Cakes for Animals, Comic Relief).
The entries, which ranged from nesting chickens, ringworm in cats and sows with piglets to beautiful vegetables and gardens, were prepared by students and staff at the campus. They were evaluated by 9 judges including members from both schools of Bioscience and Veterinary Medicine.
The cake competition also made it onto national TV this year. Apparently, Comic Relief loved the photos from the last two bake off competitions and asked for one of the bakers to design a cake for the special Comic Relief episode 'The Great British Bake Off'. Last year's public vote winners Rachael Lowton and Jennie Stoddart accepted the challenge and produced 'Just Your Everage Cake' in homage to Dame Edna.
You can see photographs of all the 2015 entries here: http://www.sbcakeoff.co.uk/entries
You can support SB Cake Off for Comic Relief here: https://www.justgiving.com/sbcakeoff/
The RCVS has advised that veterinary surgeons should delegate Schedule 3 work to veterinary nurse students only during students' training, following a series of queries from employers about such students locuming.
Veterinary surgeons have dispensations under Schedule 3 of the Veterinary Surgeons Act to delegate to student veterinary nurses in the course of their training, so that students can learn how to give medical treatments to animals.
Crucially, these dispensations apply only when the student is working as a student in their approved training practice or on a placement organised by their university, and is under the supervision of qualified staff.
These dispensations do not apply to any extra-curricula activity so, if working as locums, they are legally classified as unqualified lay staff
The RCVS is concerned that locum agencies do not always appear to know this and are placing locums in their capacity as students, or even "senior students." This has the potential to mislead employers and the students concerned, and result in illegal practice.
Liz Branscombe, Chairman of the RCVS Veterinary Nurses Council said: "We know that student VNs, especially those on university courses, often undertake locum work to supplement their earnings. However, beyond the training practice which employs them, or in a placement organised by their university, they can only carry out tasks that may be expected of an unqualified staff member, and cannot legally undertake Schedule 3 work."
Practices may check the details of a student VN directly with the RCVS or with the student's college. If you notice an agency promoting student VN locums, please contact the RCVS so that we can provide guidance.
During the four-day hearing, the Committee heard evidence in respect of three separate heads of charge brought against Mr Shah following a castration operation conducted on Shadow, a six-year old Newfoundland dog, which took place on 20 June 2014.
The three charges were as follows:
There was no complaint made as to the undertaking of the operation itself, and the Committee followed the advice from the Legal Assessor that each charge should be considered separately. When making its decision, the Committee did not take into account the fact that Shadow had died as it is impossible to say whether he would have survived had Mr Shah acted differently.
The Committee found each of the allegations against Mr Shah proved. In respect of the first charge the Committee heard from two expert witnesses, Professor Williams and Mr Plumley, who agreed that the decision to discharge Shadow at about 6pm on 20 June 2014, given his condition, was inappropriate.
The Committee considers that discharging Shadow at that time into the care of the owner given his state on discharge, was grossly negligent and a serious error of judgement. It therefore found Mr Shah to be guilty of the first charge.
The Committee then considered that, after being alerted to Shadow’s continued lack of progress by the telephone call from Gemma Ballantyne between 30 and 45 minutes after discharge, Mr Shah exacerbated the situation by the inadequacy of his response in dealing with the concerns raised which, in the Committee’s view, represented a continuation of his previous poor judgement.
The Committee considered that Mr Shah was under a duty of care to advise Gemma Ballantyne to seek urgent veterinary attention for Shadow and by his own admission he failed to do so, and he was therefore found guilty of the second charge.
During that telephone call Mr Shah also gave no further details about the out-of-hours care available to Gemma Ballantyne other than to inform her that there would be an additional cost.
He did not seek confirmation that any such information been supplied by his colleague, Emma Martin (who at the relevant time was a student nurse), however, and at no time did he see Gemma Ballantyne in possession of the discharge sheet. The Committee therefore found Mr Shah guilty of this final head of charge.
The Committee did accept that there was no element of dishonesty, nor was there an aim of financial gain in the case. The Committee also considered that Mr Shah was acting in good faith at all times. It also accepted that Mr Shah was entitled to assume that normal practice had been followed and that a previously compiled discharge sheet, containing the number of the out-of-hours provider, had been supplied to Miss Ballantyne.
Ian Green, chairing the Committee and speaking on its behalf, said: "Balancing all of the factors as the Committee must, it is clear that on this occasion Mr Shah’s conduct fell far short of that which is expected and it therefore finds he conducted himself disgracefully in a professional respect."
Mr Green added: "In imposing the sanction of a reprimand, the Committee urges Mr Shah in the strongest possible terms to ensure that his future conduct by way of training and support systems within his practice are such as to avoid any possibility of a future incident such as this occurring in order to ensure animal welfare and public confidence in the veterinary profession. The Committee notes that in her evidence, Emma Martin said that the working practices at the surgery have been changed and the Committee expects that all animals kept in the care of Mr Shah are fully monitored, examined and assessed in relation to their condition before being discharged."
MSD's push is being driven by the rising number of cases of Leishmaniasis cases in the UK, including the first report earlier this year of dog-to-dog transmission of the disease.
Caroline Darouj, Product Manager at MSD Animal Health said: "Whilst accurate statistics on the number of cases seen in UK practices are not available, the VMD has reported an annual increase in the number of leishmaniasis treatments imported since records started in 2006.
"Based on applications for Special Import Certificates for Milteforan and Glucantime, there were 27 times as many cases treated in 2018 (439) compared to 2006 (16)*.
"Leishmaniasis is proving to be a significant threat to travelling dogs, a situation that has been widely reported in the vet press, so LetiFend will offer veterinary practices and dog owners throughout the UK reassurance. A single dose primary course given four weeks before travel makes it ideal for non-regular travelers."
Letifend is indicated to reduce the risk of developing active infection and/or clinical disease after exposure to L. infantum from 28 days post vaccination1,2. It offers protection for 365 days after a single annual dose. The company says it has excellent tolerability shown in a wide range of breeds and ages, and in field trials in areas at high risk of infection had an efficacy rate of 72%4.
LetiFend is a non-adjuvanted vaccine which MSD says ensures a targeted immune response with a high level of safety.
MSD says a dog vaccinated with LetiFend is at 9.8 times less risk of presenting clinical signs, at 3.5 times less risk of presenting parasites, and thus at 5 times less risk of developing clinical leishmaniasis1. It can be applied from six months of age via subcutaneous administration.
For further information contact your MSD Animal Health account manager.
*Information from VMD following a Freedom of Information Act request.
Worth two hours of free CPD, the course has eight bitesize modules of between five and 15 minutes.
Each session is designed to improve confidence in cytology, in particular knowing when it is needed and how to take and interpret skin and ear cytology samples.
The course also includes advice on the use of dermatopicals and how to choose between Douxo S3 Pyo and Douxo S3 Calm.
The modules are presented by Natalie Barnard BVetMed, a European Veterinary Specialist in Dermatology, Amy Elvidge, an RCVS Recognised Specialist in Veterinary Dermatology, and Daniel White, a Dermatology Veterinary Nurse.
Emelie Fogelberg BSc DVM MRCVS, veterinary advisor at Ceva Animal Health said: “Skin problems can be challenging, and recurrent skin irritations are particularly frustrating.
"Cytology is essential in the work up of these cases but is often overlooked.
“Our new skin and ear cytology online course will help both vets and nurses become more confident in sample taking and interpretation to support a diagnosis and management plan from the first consultation.”
To register, visit https://veterinarywebinars.com/community/ceva/.
www.douxo.com
The debate, which was described as 'robust but good-humoured', was moderated by BEVA past-President Madeleine Campbell, sole partner at Hobgoblins Equine Reproduction Centre.
Keith Chandler, former BEVA President and member of the acquisitions team at Independent Vet Care and Karl Holliman, partner and director at Cliffe Veterinary group and past chairman of XL Equine, argued for corporatisation.
Their supporting witnesses were Lesley Barwise Munro of AlNorthumbria vets which was sold to CVS in 2015 and Julian Samuelson a former managing partner of Bell Equine, which was sold to CVS earlier this year.
In the opposing corner were Andrew Harrison, a partner at Three Counties Equine Hospital and Tim Greet, who recently retired as an equine partner at Rossdales.
Their supporting witnesses were Louise Radford MRCVS, who now works in the pharmaceutical industry and Nenad Zillic, partner at the Barn Equine Surgery.
As the moderator called 'seconds out', opinion was relatively evenly divided, with 44% of the audience agreeing with the motion and 56% disagreeing.
The pro corporatisation team advocated that obvious commercial and business advantages, together with the scale and diversity of a corporate, can give vets greater potential for a more flexible career path and advancement within the industry, and a more sustainable working career in equine practice.
Karl Holliman pointed out that corporates enable greater purchasing power, better health and safety resources, improved career structure and the freedom for employed vets to focus on clinical expertise rather than becoming bogged down with practice management.
Keith Chandler went on to argue that selling to a corporate is a solution to the problem of succession planning. In a climate of unwillingness for younger vets to buy in to practice, selling allows partners to realise the value they've built up and release that equity to do something else.
This is all very well, said Tim Greet, on the anti corporatisation panel, but the good reputation the profession currently enjoys is based on service to clients and above all the animals in our care. Clinical rather than commercial elements drive practice and partners are light on their feet and can respond quickly to decisions without referring to "a ponderous corporate hierarchy".
Tim also argued that clients like continuity and the quickest way to lose them would be to send in different vets. A bespoke approach to client care was needed rather than hard targeting.
Andrew Harrison went on to suggest that the only vets who really benefit from selling out are those who have one eye on retirement. Younger partners may be able to pay off the loan they took out to buy into practice in the first place but are then likely to take a considerable drop in salary and be given a middle management job, moving from the "pilot seat into the passenger seat." He argued that young vets cannot afford to buy into practices because the industry is being "fuelled by the corporates who are falling over themselves competing to buy equine practices and squeezing out our fellow professionals."
Pro corporatisation witness Julian Samuelson maintained that since Bell Equine has been sold to CVS there has been no change to client service, no restrictions on clinical performance and that no targets have been imposed to achieve set revenues.
Anti-corporatisation witness Louise Radford made the point that big corporates could exert pressure on pharmaceutical companies to drive down prices, which would reduce their capacity to invest in research and development trials and CPD, to the ultimate detriment of the veterinary industry.
The session closed with 72% of the audience disagreeing with the motion Corporatisation is inevitable and will benefit vets and their clients.
BEVA President Jon Pycock said: "Whether we like it or not corporatisation of equine practices is on the rise. But it shouldn’t mean that the future isn’t going to be viable for independents too as there is a role for both to co-exist. Importantly, this should mean that vets and their clients will both continue to have choices."
Written by members of BSAVA Scientific Committee, together with specialists in internal medicine and neurology, the document explains that there are limited studies showing beneficial effects of CBD, and those that there are need to be interpreted with caution as they involved small sample sizes and used unlicensed products which may have contained other components which could have influenced the results.
The document also explains that legally, CBD products must be prescribed by a veterinary surgeons and not used instead of a medication with proven efficacy.
Caroline Kisielewicz, BSAVA Scientific Committee member and one of the authors of the document said: “Information regarding the effects of cannabinoids on animals is predominantly at the stage of pre-clinical testing of individual substances in mice, rats and guinea pigs. There are limited clinical studies looking at the effects of CBD in dogs, and no reported studies in cats.
"There are many reports describing possible beneficial effects and therapeutic potential in humans, and subsequently pet owners may ask their vet about using cannabinoids to treat veterinary patients. This document aims to provide a broad overview of the available evidence base and legal position in the UK for veterinary team members."
BSAVA President, Ian Ramsey added: "The development of this information is in direct response to an increased interest in the use of CBD to treat cats and dogs. Furthermore, the guidance supports BSAVA’s mission to promote excellence in small animal practice through community, education and science."
The BSAVA position on CBD can be accessed here: https://www.bsavalibrary.com/content/chapter/10.22233/9781910443514.chap8#html_fulltext.
James qualified from Glasgow University in 2002 before joining Rosemullion Veterinary Practice, a mixed practice in Falmouth, Cornwall, of which he became a Director in 2008.
In 2014, Rosemullion separated its farm and small animal work, whereupon James became Clinical Director of the new farm practice, Coast2Coast Farm Vets.
In 2015, following the acquisition of Rosemullion and Coast2Coast by CVS, he was appointed to the group's Farm and Equine Clinical Advisory Committees. These Committees comprise clinical staff from across the Farm and Equine Divisions and make decisions on important issues, including purchasing, advice and information for its clinical teams and investments in the latest equipment and facilities.
James said: "I’ll be spending time each week travelling around the UK, Ireland and Holland to visit our farm practices and meet with colleagues within CVS and from the wider farming and veterinary industries.
"During my first six months, I’ll be focusing on developing frameworks and policies that will enable our practices to guide clients through difficult issues, such as antimicrobial and anthelmintic resistance and to help them succeed in the highly competitive marketplace for both prescription and non-prescription medicines.
"I will also be creating a bespoke farm New Graduate Programme for young vets which all our farm practices will be able to access.
"I see an exciting opportunity for CVS Farm to become a major force in the sector and am looking forward to working with my new colleagues to bring this about."
The first two episodes, which discuss feline cardiomyopathy, are available now at: https://www.buzzsprout.com/2189360 and all the leading podcast platforms (including Apple, Spotify, Amazon and Google).
Future topics will include pre-clinical feline cardiomyopathy and a practical approach to puppy murmurs.
There'll also be a number of special guests, including Prof Virginia Luis Fuentes from the Royal Veterinary College, who will discuss the treatment of feline heart disease beyond standard therapy, and Dr Brian Scansen from Colorado State University, who will talk you through the diagnosis and management of pulmonic stenosis.
To keep up with the latest from Kieran and Jose, you can follow them on Twitter or Instagram @heartbeat_pod.
They'd also love you to post to questions for their guests, or any comments you have about the podcasts, on their social media channels.
The book guides the reader through the evolutionary background of dogs and cats and explains how inherited diseases and deformities associated with certain breeds can cause breathing problems, heart disease, skin problems and back problems.
The book concludes with practical advice to help owners buy a healthy puppy or kitten and to avoid the risk of supporting puppy farms.
Emma said: "I’ve been campaigning on this issue for twenty years and, if anything the conformational issues and inherited disease problems in dogs and cats, are getting worse with some breeders striving for ever more extreme body shapes.
"Selecting a pet with inherited defects can cost thousands in vet bills and cause anguish for family members. It also creates a relinquishment problem for animal shelters as they have to take in abandoned pets with health problems.
"While awareness is certainly increasing, too often prospective pet owners are still unaware of the health implications of the pet they are buying and it is difficult for my veterinary colleagues to criticise the choice of a client’s puppy or kitten once it has been bought. All too often though they are left to pick up the pieces."
Emma added: "Education is the key. It is vital that prospective owners understand why different body shapes could be detrimental to health and how far removed from nature some of our breeds now are. If we can encourage them to stop choosing the quirky extremes in some breeds, demand for them will soon fall. My message is simple – we should all prioritise health and temperament way above what animals look like.
"I hope that responsible prospective pet owners will find Picking a Pedigree? an enlightening read and that it will inform their choice of a new family member. I also hope that it will be a useful resource for vets and nurses to be able to recommend to reinforce their pre-purchase advice."
The Good Veterinary Workplaces Voluntary Code sets out various criteria for what makes a good workplace, based on a new evidence-based BVA policy position.
The code is accompanied by a workbook which veterinary teams can work through together and consider how they might meet a range of criteria. They can also download, sign and display a Voluntary Code poster signalling their commitment to working towards being a good veterinary workplace.
Teams will be asked to assess what they already do well in areas including health and wellbeing, diversity and equality, workload and flexibility, and providing opportunities for personal and career development, as well as identifying areas for improvement and any HR and management processes that need to be put in place to achieve a positive workplace culture.
At the same time, the BVA has also launched its Good Veterinary Workplaces policy position, a paper which offers 64 recommendations for employers and staff on how to offer a fair and rewarding work environment where everyone feels valued.
The BVA says it decided to develop the Good Veterinary Workplaces policy off the back of an extensive body of work looking at workforce issues in the profession, including recruitment and retention challenges, a lack of diversity across the workforce, and general high levels of stress and burn-out in veterinary teams.
The joint BVA/RCVS-led Vet Futures project identified the need to explore the work-related challenges facing vets and take action to create a sustainable and thriving workforce that can maximise its potential.
Gudrun Ravetz, Chair of the Good Workplace Working Group, said: “I’m absolutely delighted to see the launch of our valuable and comprehensive policy, which sets out a vision of the good veterinary workplaces that we should all be striving to create across the profession. This vision has been shaped by valuable contributions from across the veterinary community, and it’s also been really useful to draw on good practice in the wider world of work.
“Each and every one of us deserves to work in a setting where we feel valued, supported and fairly rewarded for the contribution we make, but sadly this isn’t the reality for all veterinary professionals. By setting out the steps that all veterinary workplaces can take to offer a more welcoming and inclusive environment, with measures in place to help them address issues and continue to improve, we hope to see more workplaces where staff can thrive and enjoy a fulfilling career.”
Daniella Dos Santos, BVA Senior Vice President, said: “It’s time for us all to take action to create a culture shift in veterinary workplaces. That means taking positive steps so that diversity and inclusion is championed at all levels, all team members have access to personal and professional development opportunities, and there is recognition that prioritising staff wellbeing is good for businesses.
“In creating the Voluntary Code and workbook, we’ve purposefully made this something that isn’t driven from the top down but is instead something that everyone in the team can feel empowered to feed into and sign up to. This is a golden opportunity for our profession to take ownership of our workplaces, improve conditions, and make sure that we have positive working environments in which we can all take pride.”
Containing ceftiofur (50mg/ml) and ketoprofen (150mg/ml), Curacef Duo is presented in a ready-to-use suspension for injection at a low volume dosage – 1 ml/50kg – which is identical to short-acting ceftiofur alone.
Virbac says that Curacef Duo’s combined action can help to minimise production losses in calves and offer a quick return to production for dairy cows affected by bacterial BRD. It can also improve welfare by targeting infection, inflammation and pain all at once, while its ease of use and simple dosing help to increase compliance. Curacef Duo offers a zero milk withdrawal period and an eight day withdrawal period in meat.
Brigitte Goasduf MRCVS, Large Animal Product Manager at Virbac, said: "In creating the first 'two-in-one' combination of two tried and trusted actives, the antibiotic ceftiofur and NSAID ketoprofen, we are offering practitioners an alternative to the treatment of bacterial BRD.
"We believe that the benefits Curacef Duo offers in terms of efficacy, ease of use and action on inflammation and pain, will be valued by both practitioners and farmers."
The new app, which is being being made available in the run up to Pet Diabetes Month in November, allows owners to track water and food consumption, exercise, glucose levels and insulin injections on their smartphone or tablet. It can also send reminders for veterinary appointments and insulin injections, and creates charts that clients can share with their veterinary surgeon.
MSD says the Pet Diabetes Tracker will help improve client reporting and compliance, resulting in improved pet welfare and a reduction in risk to pets through its alert system.
Caroline Darouj, Product Manager at MSD Animal Health said: "To help ensure the long-term health and well-being of a pet, successfully managing the various facets of the disease and treatments is critical.
"With proper management and monitoring a dog or cat with diabetes can lead a healthy, happy and active life, and the Pet Diabetes Tracker can help make it happen. This is an incredibly useful tool that links the pet owner with the vet and puts all the pertinent diabetic health information at their fingertips. It’s all about setting habits that save lives!"
The Pet Diabetes Tracker can be downloaded from iTunes, here: https://itunes.apple.com/uk/app/pet-diabetes-tracker-uk/id1284472796?ls=1&mt=8.
MSD says an Android version will also be available soon.
For more information, visit www.petdiabetesmonth.co.uk or contact your MSD Animal Health account manager.
Vetoquinol UK Limited has launched Ceftiocyl: a ready-to-use formulation containing 50mg/ml ceftiofur for use in cattle and pigs.
In cattle, Ceftiocyl can be used for the treatment of respiratory disease, acute interdigital necrobacillosis and acute post-partum metritis. In pigs, Ceftiocyl is licensed for the treatment of respiratory disease. Ceftiocyl has the added benefit of traceability stickers which are attached to each vial making it easier and quicker to record and monitor on-farm usage.
Susan Mitchell, Large Animal Product Manager at Vetoquinol UK Ltd said, 'We are delighted to be expanding our large animal anti infective range offering. Marbocyl 10% has been used for acute mastitis in the dairy sector for many years, the addition of Ceftiocyl to our portfolio enables us to provide a cost-effective treatment for both metritis and lameness.'
1. Willshire, J.A. & Bell, N, J. (2009) An economic review of cattle lameness. Cattle Practice 17, 136-141.
The award recognises an exceptional farm vet who has been working in the dairy industry for three to five years and contributed significantly to the health and wellbeing of the herds under their care.
Rob joined LLM Vets after graduating from Cambridge University Vet School in 2017. He has particular interests in lameness, calf rearing and housing design. He said: “Since joining LLM, I have thrown myself into all aspects of the practice – from the Agricultural Show season to driving LLM’s BVD eradication efforts and revamping our herd health planning scheme. My role in practice management is also growing. I currently oversee work for the Johnes CHeCS programme and help to guide our industry-leading team of VetTechs."
He added: “I find the interaction between dairy cattle and their environment fascinating and, following some specialist training I undertook with the Dairyland Initiative in Wisconsin, I’ve been helping our farmers to make major changes to their cow and calf housing, particularly by improving ventilation.”
CREAM judge Rob Drysdale said: “Rob Hall really stood out because of the additional services he’s trying to offer, for instance, getting involved in the Stamping Out BVD campaign and utilising his specialist skills in calf housing ventilation to increase welfare standards. Rob would be a real asset to any farm or vet business.”
Charlotte Read, Key Account Manager – Farm, at Krka, added: “Newly qualified vets represent the future of this exciting and rapidly-evolving profession so we are particularly delighted to have the opportunity to highlight their achievements. Krka is proud to support the UK’s dairy sector and we congratulate both Rob and Rupert on the huge contribution they are making to their clients and their practices.”